Given its critical role in cell cycle regulation, the inhibition of PLK1 activity has been shown to significantly inhibit the proliferation of a wide range of cancer cell lines, thus emphasizing its considerable promise as a therapeutic target for cancer therapy. Here, PLK1 is linked to cancer.